SCHEMBL28980925

SCHEMBL28980925

O=C1NCC(=O)N2CCN(Cc3ccc4ccc5cccc6ccc3c4c56)CC12

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.50
▸ POLB P06746 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.47
▸ FAAH O00519 1/20 0.43
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.32
▸ PDCD1LG2 Q9BQ51 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ HTR1A P08908 1/20 0.31
▸ ACHE P22303 1/20 0.30
▸ SCN9A Q15858 1/20 0.30
▸ GBA1 P04062 2/20 0.30
▸ UGCG Q16739 2/20 0.30
▸ GBA2 Q9HCG7 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30337109 0.85 TSHR (0.47) FAAHMEN1KMT2ATSHRGPR84
SCHEMBL30337245 0.79 HTR1A (0.47) KDM4EPOLBHTTALDH1A1FAAH
SCHEMBL30337432 0.78 ALDH1A1 (0.46) POLBALDH1A1MEN1KMT2ATSHR
SCHEMBL24939910 0.77 HTR6 (0.41) ALDH1A1FAAHMEN1KMT2ATSHR
SCHEMBL30336973 0.76 KMT2A (0.49) POLBFAAHMEN1KMT2AACHE
SCHEMBL28980935 0.76 KDM4E (0.47) KDM4EPOLBHTTALDH1A1MEN1
SCHEMBL30337569 0.76 KDM4E (0.46) KDM4EPOLBHTTALDH1A1FAAH
SCHEMBL30337145 0.76 KDM4E (0.45) KDM4EPOLBHTTALDH1A1FAAH
SCHEMBL24152329 0.75 GSK3B (0.50) ALDH1A1
SCHEMBL24939934 0.75 CYP2D6 (0.56) KDM4EPOLBHTTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916206-A Novel compound and pharmaceutical composition for preventing or treating resistant cancer comprising same 治愈医药社株式会社 2023-04-04 — — CN disclosed
Send feedback